Headlines about SeaSpine (NASDAQ:SPNE) have trended somewhat positive recently, according to Accern. The research group ranks the sentiment of news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. SeaSpine earned a news sentiment score of 0.11 on Accern’s scale. Accern also assigned news articles about the medical equipment provider an impact score of 47.0447879099988 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
A number of research analysts have recently commented on SPNE shares. Ladenburg Thalmann Financial Services started coverage on SeaSpine in a research report on Thursday, December 14th. They set a “buy” rating and a $20.00 target price for the company. Zacks Investment Research downgraded SeaSpine from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. HC Wainwright set a $15.00 target price on SeaSpine and gave the company a “buy” rating in a research report on Friday, March 2nd. BTIG Research reiterated a “buy” rating and set a $17.00 target price on shares of SeaSpine in a research report on Friday, March 2nd. Finally, ValuEngine upgraded SeaSpine from a “sell” rating to a “hold” rating in a research report on Monday. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $17.20.
NASDAQ:SPNE opened at $10.64 on Friday. SeaSpine has a fifty-two week low of $7.37 and a fifty-two week high of $13.46. The firm has a market cap of $145.23, a P/E ratio of -4.12 and a beta of 0.33.
COPYRIGHT VIOLATION WARNING: This story was first published by BBNS and is the sole property of of BBNS. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://baseballnewssource.com/2018/04/06/seaspine-spne-earns-daily-news-sentiment-rating-of-0-11/2030057.html.
SeaSpine Company Profile
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical regions of the spine.
Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with MarketBeat.com's FREE daily email newsletter.